• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型液相色谱法定量测定瑞德西韦注射液中降解产物。

A Novel Liquid Chromatographic Method for the Quantitative Determination of Degradation Products in Remdesivir Injectable Drug product.

机构信息

Research and Development Centre, Bharathiar University, Coimbatore 641046, Tamil Nadu, India.

Research and Development Centre, Department of Chemistry, Shridevi Institute of Engineering and Technology, Tumkur 572106, Karnataka, India.

出版信息

J Chromatogr Sci. 2022 Feb 16;60(2):194-200. doi: 10.1093/chromsci/bmab042.

DOI:10.1093/chromsci/bmab042
PMID:33948643
Abstract

An effectual and stability signifying technique has been validated for the quantitative verification of degradation products in Remdesivir Injectable pharmaceutical products by employing high-performance liquid chromatography with ultraviolet detector. The process was optimized by using an octyldecylsilane chemically bonded column (Kromasil KR100-5 C18; USP L1 phase) with dimensions; 250 mm length × 4.5 mm inner diameter and 5-μm particle size. The method was validated as per International Conference on Harmonization and other current regulatory guidelines for analytical method validation. The anticipated process was found to be robust, accurate, specific, linear, precise, stable and rugged in the concentration ranging from quantification level to 200% of the specification level of specified and unknown degradation impurities. The technique was effectively applied to analyze degradation products in Remdesivir Injectable drug products.

摘要

高效液相色谱法-紫外检测法用于定量检测雷迪西韦注射剂中降解产物,该方法已被验证为有效且稳定的检测方法。采用辛基硅烷键合柱(Kromasil KR100-5 C18;USP L1 相),柱长 250mm,内径 4.5mm,粒径 5μm,对该方法进行了优化。方法按照国际协调会议和其他现行法规指南进行了分析方法验证。研究发现,该方法在定量下限到规定和未知降解杂质 200%的浓度范围内具有较强的耐用性、准确性、特异性、线性、精密度、稳定性和耐用性。该技术已成功应用于分析雷迪西韦注射剂中的降解产物。

相似文献

1
A Novel Liquid Chromatographic Method for the Quantitative Determination of Degradation Products in Remdesivir Injectable Drug product.一种新型液相色谱法定量测定瑞德西韦注射液中降解产物。
J Chromatogr Sci. 2022 Feb 16;60(2):194-200. doi: 10.1093/chromsci/bmab042.
2
A validated stability-indicating reversed-phase-HPLC method for dipyridamole in the presence of degradation products and its process-related impurities in pharmaceutical dosage forms.在药物制剂中存在降解产物和其工艺相关杂质的情况下,对双嘧达莫进行稳定性指示的反相高效液相色谱法的验证。
Biomed Chromatogr. 2022 Jan;36(1):e5247. doi: 10.1002/bmc.5247. Epub 2021 Oct 21.
3
Development and Validation of High-Performance Liquid Chromatography Method for the Quantification of Remdesivir in Intravenous Dosage Form.开发并验证高效液相色谱法用于静脉注射剂型中瑞德西韦的定量分析。
Assay Drug Dev Technol. 2021 Nov-Dec;19(8):475-483. doi: 10.1089/adt.2021.074. Epub 2021 Oct 18.
4
UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.超高效液相色谱法(UPLC)和液相色谱 - 质谱联用(LC - MS)对盐酸伊立替康降解行为的研究以及开发一种经验证的稳定性指示超高效液相色谱法,用于测定药物剂型中盐酸伊立替康及其杂质。
J Chromatogr Sci. 2012 Oct;50(9):810-9. doi: 10.1093/chromsci/bms075. Epub 2012 Jun 1.
5
A rapid RP-HPLC stability-indicating method development and validation of moxifloxacin hydrochloride-related substances in finished dosage forms.一种快速反相高效液相色谱法用于成品剂型中盐酸莫西沙星相关物质的稳定性指示方法开发与验证。
Biomed Chromatogr. 2021 Nov;35(11):e5192. doi: 10.1002/bmc.5192. Epub 2021 Jun 23.
6
Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.建立并验证了一种新型的 HPLC 稳定性指示法,用于定量测定依泽替米贝原料药及制剂中十一相关物质。
Talanta. 2015 Jul 1;139:67-74. doi: 10.1016/j.talanta.2015.02.039. Epub 2015 Feb 27.
7
Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.用于同时测定药物制剂中甲磺酸雷沙吉兰工艺相关杂质和降解产物的稳定性指示反相高效液相色谱法的开发与验证
J Chromatogr Sci. 2013 Mar;51(3):242-9. doi: 10.1093/chromsci/bms134. Epub 2012 Sep 17.
8
Quantitative HPLC-MS/MS determination of Nuc, the active metabolite of remdesivir, and its pharmacokinetics in rat.定量高效液相色谱-串联质谱法测定瑞德西韦的活性代谢产物 Nuc 在大鼠体内的药代动力学。
Anal Bioanal Chem. 2021 Sep;413(23):5811-5820. doi: 10.1007/s00216-021-03561-8. Epub 2021 Jul 24.
9
Development, validation and forced degradation studies of green liquid chromatographic method for determination of remdesivir in bulk drug and pharmaceutical formulation.用于测定原料药和药物制剂中瑞德西韦的绿色液相色谱法的开发、验证及强制降解研究
Pak J Pharm Sci. 2023 Jan;36(1):159-170.
10
A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.在降解产物和其工艺相关杂质存在的情况下,对乙酰唑胺进行稳定性指示的验证型 LC 方法。
J Pharm Biomed Anal. 2010 May 1;52(1):142-8. doi: 10.1016/j.jpba.2009.12.011. Epub 2009 Dec 14.

引用本文的文献

1
Eco-friendly spectrofluorimetric determination of remdesivir in the presence of its metabolite in human plasma for therapeutic monitoring in COVID-19 patients.在新冠患者血浆中存在瑞德西韦代谢物的情况下,采用环保型荧光光谱法测定瑞德西韦用于治疗监测。
Sci Rep. 2025 Jun 23;15(1):20251. doi: 10.1038/s41598-025-05198-4.
2
Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation.使用分光光度法对加标的人血浆中两种新冠病毒抗病毒药物法匹拉韦和瑞德西韦进行定量分析;绿色度评估。
BMC Chem. 2023 Jun 16;17(1):58. doi: 10.1186/s13065-023-00967-6.
3
Remdesivir.
瑞德西韦。
Profiles Drug Subst Excip Relat Methodol. 2023;48:71-108. doi: 10.1016/bs.podrm.2022.11.003. Epub 2023 Feb 9.
4
Simultaneous spectrofluorimetic determination of remdesivir and simeprevir in human plasma.同时荧光光度法测定人血浆中瑞德西韦和西美瑞韦。
Sci Rep. 2022 Dec 20;12(1):21980. doi: 10.1038/s41598-022-26559-3.
5
Eco-friendly stability-indicating HPTLC micro-determination of the first FDA approved SARS-CoV-2 antiviral prodrug Remdesivir: Study of degradation kinetics and structural elucidation of the degradants using HPTLC-MS.生态友好型稳定性指示高效薄层色谱法微测定首个获美国食品药品监督管理局批准的抗新型冠状病毒2型抗病毒前药瑞德西韦:利用高效薄层色谱-质谱联用研究降解动力学及降解产物的结构解析
Sustain Chem Pharm. 2022 Oct;29:100744. doi: 10.1016/j.scp.2022.100744. Epub 2022 Jun 14.
6
Environmental impact of the reported chromatographic methods for the determination of the first FDA-Approved therapy for COVID-19 Patients, Remdesivir: A comparative study.用于测定首个获美国食品药品监督管理局批准的新冠肺炎患者治疗药物瑞德西韦的色谱方法的环境影响:一项比较研究。
Microchem J. 2022 May;176:107242. doi: 10.1016/j.microc.2022.107242. Epub 2022 Jan 30.